BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 31, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Other news to note for Oct. 20, 2020

Oct. 20, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acorda, Affimed, Arecor, Atriva, Baudax, Biogen, Cara, Chelation, Citranvi, CNS Pharmaceuticals, Cytovant, Dinona, Gigagen, Havn, Hikma, Immunic, Immunomedics, Incelldx, Intrommune, Kineta, Medigene, Mindset, Nascent, Nevakar, Nkmax, Organicell, Oric, Parexel, Proteonic, Revive, Samsung Biologics, Synairgen, Synspira, Tetra, Tscan, Vifor, Voronoi, Zhaoke.
Read More

In the clinic for Oct. 20, 2020

Oct. 20, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abpro, Aclaris, Appili, Aptinyx, Bone, Cardiff, Cincor, Cytodyn Evofem, Jazz, Keros, Merck, Neuclone, Neuraptive, Noxxon, Ono, Rafael, TFF, Treadwell, Valneva.
Read More

Regulatory actions for Oct. 19 2020

Oct. 19, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Biosensors International, Centogene, DNA Genotek, Dxterity, Everlywell, Fresenius Medical Care, Ossio, Thermo Fisher Scientific.
Read More

Other news to note for Oct. 19, 2020

Oct. 19, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3M, Abbott, Apollo Medco, Beahm Designs, BD, Beroni Group, Caredx, Eko, Genscript Biotech, Labcorp, Machine Solutions, Medovate, Plexision, Quidel, Vygon.
Read More

Regulatory actions for Oct. 19, 2020

Oct. 19, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Agios, Astrazeneca, Bristol Myers Squibb, Dr. Reddy's, Edesa, Exelixis, Genentech, Gilead, Intellia, Matinas, Mereo, Neurelis, Octapharma, Oncopeptides, Prestige, Recce, Roche, Versantis.
Read More

Other news to note for Oct. 19, 2020

Oct. 19, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Akron, Aridis, Beyond Air, Bioeleven, Brainstorm, Biospecifics, Cardinal, Catalyst, Cocrystal, Cognition, Connectyx, Endo, Evotec, Genentech, Genesis, Huadong, Immunogen, Just-Evotec, Kamada, Kazia, Koligo, NGM, Oncomyx, Orgenesis, Tissue Genesis, Samsung, Sanofi, Sesen, Som, Sunshine, Synairgen, Transcelerate, Translate.
Read More
Coronavirus, lungs, hand holding stethoscope

Nec partners with Oslo University Hospital to develop AI-based diagnostic for COVID-19

Oct. 16, 2020
By Elise Mak
Nec Corp.’s bioinformatics subsidiary Nec Oncoimmunity AS said it is working with Oslo University Hospital to develop an artificial intelligence (AI) platform that will allow the team to design a T-cell diagnostic to complement the current serological tests for infectious diseases, including COVID-19.
Read More
Petri dishes
BIF 2020

No time to lose to curb rising tide of antimicrobial resistance

Oct. 16, 2020
By Peter Winter
In July a major initiative of the International Federation of Pharmaceutical Manufacturers and Associations, designed to combat the rising tide of antimicrobial resistance and accelerate the pace at which new antibiotics are discovered and brought to market, was announced. The $1 billion AMR Action Fund, supported by 23 pharma companies, was created “because there was a clear realization that we have no time to spare to address the lack of innovation in this area,” said Martin Bott, interim general manager of the fund, who described the progress being made with the fund in a fireside chat at this week’s virtual BIO Investor Forum.
Read More

Regulatory actions for Oct. 16, 2020

Oct. 16, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Becton Dickinson, Genalyte.
Read More

Other news to note for Oct. 16, 2020

Oct. 16, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Altrix Medical, Chembio Diagnostics, Eurofins Biomnis, Jud Care, Luxfer, Myriad Genetics, Neurox, Nexgel, Stratus, Transforming Systems, Ursa Health, Vitalhub.
Read More
Previous 1 2 … 352 353 354 355 356 357 358 359 360 … 552 553 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 29, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 26, 2026
  • Floating antibody drug conjugates

    TROP2 ADCs progress into first-line for lung, breast cancers

    BioWorld
    Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
  • Microscopy of a cross-section of mouse skin containing melanoma tumors

    Researchers identify innate immune barrier against melanoma

    BioWorld
    Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
  • Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers

    BioWorld Science
    Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing